Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label biodegradable sensors. Show all posts
Showing posts with label biodegradable sensors. Show all posts

Tuesday, January 14, 2025

Biodegradable Brain Electrodes Advance Neural Repair

 Do you have ANY proof this actually created recovery in stroke patients?

Biodegradable Brain Electrodes Advance Neural Repair

Summary: Researchers have developed a flexible, biodegradable electrode capable of stimulating neural precursor cells (NPCs) in the brain, offering a safer and more precise alternative for neural repair. The electrode dissolves naturally after seven days, eliminating the need for surgical removal while promoting tissue regeneration.

Made from FDA-approved materials, the device successfully increased NPC activity in preclinical models without causing significant inflammation or damage. This innovation could significantly expand treatment options for neurological disorders, which are a leading cause of disability worldwide.

Future developments aim to integrate drug and gene therapy delivery into the electrodes for enhanced therapeutic potential.

Key Facts:

  • Innovative Design: The biodegradable electrode stimulates neural repair without requiring surgical removal.
  • Targeted Activation: Stimulating neural precursor cells boosts repair of damaged brain tissue.
  • Future Potential: Researchers plan to integrate drug and gene therapies into the device.

Source: University of Toronto

University of Toronto researchers have developed a flexible, biodegradable electrode capable of stimulating neural precursor cells (NPCs) in the brain – a device capable of delivering targeted electrical stimulation for up to seven days before it dissolves naturally.

By harnessing the body’s innate repair mechanisms, the researchers’ approach represents a potential step forward in the treatment of neurological disorders that are a leading cause of disability worldwide.

This shows a brain.
To design the biodegradable neural probe, the team focused on materials that provided both biocompatibility and tunable degradation rates. Credit: Neuroscience News

While neurological disorders often result in irreversible cell loss, stimulating NPCs – rare cells capable of repairing neural tissue – has shown promise when it comes to expanding limited treatment options.

However, existing methods such as transcranial direct current stimulation lack precision and can damage tissue. The electrode developed by U of T researchers, on the other hand, provides precise, safe and temporary stimulation without requiring subsequent surgical interventions.  

“Our findings demonstrate that this electrode can stimulate neural repair in a controlled, temporary manner, which is crucial for avoiding complications associated with permanent implants,” says Tianhao Chen, a PhD student in biomedical engineering who is the study’s lead author.  

The research, published in a recent issue of Biomaterials, was led by Hani Naguib, a professor in the departments of materials science and engineering and mechanical and industrial engineering in the Faculty of Applied Science & Engineering, and Cindi Morshead, a professor of surgery in the Temerty Faculty of Medicine who is cross-appointed to the Institute of Biomedical Engineering.

“Neural precursor cells hold significant potential for repairing damaged brain tissue, but existing methods for activating these cells can be invasive or imprecise,” Morshead says.  

“Our biodegradable electrode provides a solution by combining effective stimulation with reduced patient risk.”  

To design the biodegradable neural probe, the team focused on materials that provided both biocompatibility and tunable degradation rates. 

Poly(lactic-co-glycolic) acid (PLGA), a flexible material approved by the U.S. Food and Drug Administration, was chosen for the substrate and insulation layer due to its predictable degradation based on monomer ratios and minimal inflammatory effects.  

Molybdenum was selected for the electrode itself due to its durability and slow dissolution – both qualities essential for maintaining structural integrity during the intended one-week stimulation period.  

The electrodes were implanted in pre-clinical models and demonstrated the ability to stimulate NPCs effectively, increasing their numbers and activity without causing significant tissue damage or inflammation.

This testing ensured the electrodes’ safety and efficacy for neural repair stimulation within the targeted time frame.  

“Our plan is to further develop this technology by creating multimodal, biodegradable electrodes that can deliver drugs and gene therapies to the injured brain,” says Morshead.  

“We have exciting data to show that activating brain stem cells with our electrical stimulation devices improves functional outcomes in a preclinical model of stroke.” 

About this neurology and neurotech research news

Author: Qin Dai
Source: University of Toronto
Contact: Qin Dai – University of Toronto
Image: The image is credited to Neuroscience News

Original Research: Open access.
Biodegradable stimulating electrodes for resident neural stem cell activation in vivo” by Tianhao Chen et al. Biomaterials

Tuesday, January 23, 2018

New biodegradable pressure sensor could help monitor serious health conditions

You might want to mention this to your doctor if you have brain swelling from a hemorrhage. 

New biodegradable pressure sensor could help monitor serious health conditions


UConn engineers have created a biodegradable pressure sensor that could help doctors monitor chronic lung disease, swelling of the brain, and other medical conditions before dissolving harmlessly in a patient's body.
The UConn research is featured in the current online issue of the Proceedings of the National Academy of Sciences.
The small, flexible sensor is made of medically safe materials already approved by the U.S. Food and Drug Administration for use in surgical sutures, bone grafts, and medical implants. It is designed to replace existing implantable pressure sensors that have potentially toxic components.
Those sensors must be removed after use, subjecting patients to an additional invasive procedure, extending their recovery time, and increasing the risk of infection.
Because the UConn sensor emits a small electrical charge when pressure is applied against it, the device also could be used to provide electrical stimulation for tissue regeneration, researchers say. Other potential applications include monitoring patients with glaucoma, heart disease, and bladder cancer.
"We are very excited because this is the first time these biocompatible materials have been used in this way," says Thanh Duc Nguyen, the paper's senior author and an assistant professor of mechanical and biomedical engineering in the Institute of Regenerative Engineering at UConn Health and the Institute of Materials Science at the Storrs campus.
"Medical sensors are often implanted directly into soft tissues and organs," Nguyen notes. "Taking them out can cause additional damage. We knew that if we could develop a sensor that didn't require surgery to take it out, that would be really significant."
A prototype sensor made by the lab consisted of a thin polymer film five millimeters long, five millimeters wide, and 200 micrometers thick. The sensor was implanted in the abdomen of a mouse in order to monitor the mouse's respiratory rate. It emitted reliable readings of contractions in the mouse's diaphragm for four days before breaking down into its individual organic components.
To make sure the sensor was also medically safe, the researchers implanted it in the back of a mouse and then watched for a response from the mouse's immune system. The results showed only minor inflammation after the sensor was inserted, and the surrounding tissue returned to normal after four weeks.
One of the project's biggest challenges was getting the biodegradable material to produce an electrical charge when it was subjected to pressure or squeezed, a process known as the piezoelectric effect. In its usual state, the medically safe polymer used for the sensor - a product known as Poly(L-lactide) or PLLA - is neutral and doesn't emit an electrical charge under pressure.
Eli Curry, a graduate student in Nguyen's lab and the paper's lead author, provided the project's key breakthrough when he successfully transformed the PLLA into a piezoelectric material by carefully heating it, stretching it, and cutting it at just the right angle so that its internal molecular structure was altered and it adopted piezoelectric properties. Curry then connected the sensor to electronic circuits so the material's force-sensing capabilities could be tested.
When put together, the UConn sensor is made of two layers of piezoelectric PLLA film sandwiched between tiny molybdenum electrodes and then encapsulated with layers of polylactic acid or PLA, a biodegradable product commonly used for bone screws and tissue scaffolds. Molybdenum is used for cardiovascular stents and hip implants.
The piezoelectric PLLA film emits a small electrical charge when even the most minute pressure is applied against it. Those small electrical signals can be captured and transmitted to another device for review by a doctor.
As part of their proof of concept test for the new sensor, the research team hardwired an implanted sensor to a signal amplifier placed outside of a mouse's body. The amplifier then transmitted the enhanced electrical signals to an oscilloscope where the sensor's readings could be easily viewed.
The sensor's readings during testing were equal to those of existing commercial devices and just as reliable, the researchers say. The new sensor is capable of capturing a wide range of physiological pressures, such as those found in the brain, behind the eye, and in the abdomen. The sensor's sensitivity can be adjusted by changing the number of layers of PLLA used and other factors.
Nguyen's group is investigating ways to extend the sensor's functional lifetime. The lab's ultimate goal is to develop a sensor system that is completely biodegradable within the human body.
But until then, the new sensor can be used in its current form to help patients avoid invasive removal surgery, the researchers say.
"There are many applications for this sensor," says Nguyen. "Let's say the sensor is implanted in the brain. We can use biodegradable wires and put the accompanying non-degradable electronics far away from the delicate brain tissue, such as under the skin behind the ear, similar to a cochlear implant. Then it would just require a minor treatment to remove the electronics without worrying about the sensor being in direct contact with soft brain tissue."
Nguyen's research group has filed for a patent for the new sensor. The patent application is pending.